Expert Interview
A First look at the safety and efficacy of Lumateperon in treating bipolar depression.
Ticker(s): ITCIInstitution: NY Presbyterian
- Professor of Psychiatry at Weill Cornell Medicine, Attending Psychiatrist at the New York-Presbyterian Hospital and Director of the Affective Disorders Research Program at the Payne Whitney Psychiatric Clinic.
-
Currently managing 75 patients with major depressive episodes and bipolar disorder
-
His research interests include Pharmacotherapy and Psychotherapy of Dysthymia and Chronic Depression, as well as Depression in special populations such as substance abusers and patients infected with the Human Immunodeficiency Virus.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
